Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.455
0.00 (0.00%)
Nov 14, 2025, 9:59 AM AEST
Imricor Medical Systems Market Cap
Imricor Medical Systems has a market cap or net worth of 466.98 million as of November 13, 2025. Its market cap has increased by 150.50% in one year.
Market Cap
466.98M
Enterprise Value
428.03M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.46
Market Cap Chart
Since August 30, 2019, Imricor Medical Systems's market cap has increased from 87.01M to 466.98M, an increase of 436.69%. That is a compound annual growth rate of 31.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 466.98M | 27.09% |
| Dec 31, 2024 | 367.44M | 281.62% |
| Dec 29, 2023 | 96.28M | 74.29% |
| Dec 30, 2022 | 55.24M | -61.62% |
| Dec 31, 2021 | 143.95M | -49.27% |
| Dec 31, 2020 | 283.74M | 155.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.55B |
| Pro Medicus | 26.88B |
| Cochlear | 18.75B |
| Sonic Healthcare | 10.44B |
| Ramsay Health Care | 7.08B |
| Ansell | 5.24B |
| Telix Pharmaceuticals | 5.05B |
| Mesoblast | 3.00B |